Bibliotecas PUC-SP - Busca Integrada

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy

по Jie Yin, Jie Yin, James M. Markert, James M. Markert, James M. Markert, Jianmei W. Leavenworth, Jianmei W. Leavenworth
Опубликовано в: Frontiers in Oncology (2017-06-01)

Bilateral metastatic renal hemangiopericytoma ten years after primary intracranial lesion

по Lee N. Hammontree, Kristopher Whitehead, James M. Markert
Опубликовано в: International Brazilian Journal of Urology (2006-06-01)

Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells.

по James J Cody, James M Markert, Douglas R Hurst
Опубликовано в: PLoS ONE (2014-01-01)

Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors

по Taylor M. Pearl, James M. Markert, Kevin A. Cassady, Mohammed G. Ghonime
Опубликовано в: Molecular Therapy: Oncolytics (2019-06-01)

Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma

по Dahye Park, Mina Lobbous, Louis B Nabors, James M Markert, Jinsuh Kim
Опубликовано в: CNS Oncology (2022-12-01)

Human Herpesviridae Methods of Natural Killer Cell Evasion

по Carl I. Odom, David C. Gaston, James M. Markert, Kevin A. Cassady
Опубликовано в: Advances in Virology (2012-01-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses

по Kevin A. Cassady, Kellie B. Haworth, Josh Jackson, James M. Markert, Timothy P. Cripe
Опубликовано в: Viruses (2016-02-01)

Alteration of the threshold stimulus for intraoperative brain mapping via use of antiepileptic medications

по John W. Amburgy, MD, Robert C. Foster, BS, Neil Billeaud, MD, James M. Markert, MD
Опубликовано в: Interdisciplinary Neurosurgery (2015-03-01)

Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases

по James J. Cody, Pietro Scaturro, Alan B. Cantor, G. Yancey Gillespie, Jacqueline N. Parker, James M. Markert
Опубликовано в: International Journal of Breast Cancer (2012-01-01)

Spontaneous cerebellar hemorrhage in a patient taking apixaban

по Christopher D. Shank, MD, Esther B. Dupépé, MD, MSPH, Kara A. Sands, MD, James M. Markert, MD
Опубликовано в: Interdisciplinary Neurosurgery (2015-03-01)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy

по Gregory K Friedman, Joel eRaborn, Virginia M Kelly, Kevin A Cassady, James M Markert, George Yancey Gillespie
Опубликовано в: Frontiers in Oncology (2013-02-01)

Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

по Meagan Mandabach Olivet, Michael C. Brown, Zachary J. Reitman, David M. Ashley, Gerald A. Grant, Yuanfan Yang, James M. Markert
Опубликовано в: Cancers (2023-07-01)

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma

по David F. Bauer, Larisa Pereboeva, G. Yancey Gillespie, Gretchen A. Cloud, Osama Elzafarany, Catherine Langford, James M. Markert, Lawrence S. Lamb Jr.
Опубликовано в: Journal of Immunology Research (2016-01-01)

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas

по Lawrence S. Lamb, Larisa Pereboeva, Samantha Youngblood, G. Yancey Gillespie, L. Burton Nabors, James M. Markert, Anindya Dasgupta, Catherine Langford, H. Trent Spencer
Опубликовано в: Scientific Reports (2021-10-01)

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates

по Kevin A. Cassady, David F. Bauer, Justin Roth, Melissa R. Chambers, Trent Shoeb, Jennifer Coleman, Mark Prichard, G. Yancey Gillespie, James M. Markert
Опубликовано в: Molecular Therapy: Oncolytics (2017-06-01)

Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.

по David C Gaston, Carl I Odom, Li Li, James M Markert, Justin C Roth, Kevin A Cassady, Richard J Whitley, Jacqueline N Parker
Опубликовано в: PLoS ONE (2013-01-01)

Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory

по Mohammed G. Ghonime, Josh Jackson, Amish Shah, Justin Roth, Mao Li, Ute Saunders, Jennifer Coleman, G. Yancey Gillespie, James M. Markert, Kevin A. Cassady
Опубликовано в: Translational Oncology (2018-02-01)

Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma

по Jeffrey M. Grimes, Sadashib Ghosh, Shamza Manzoor, Li X. Li, Monica M. Moran, Jennifer C. Clements, Sherrie D. Alexander, James M. Markert, Jianmei W. Leavenworth
Опубликовано в: Nature Communications (2025-01-01)

Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma

по Justin T. Low, Michael C. Brown, Zachary J. Reitman, Joshua D. Bernstock, James M. Markert, Gregory K. Friedman, Matthew S. Waitkus, Michelle L. Bowie, David M. Ashley
Опубликовано в: The Journal of Clinical Investigation (2024-01-01)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma

по Alicia M. Waters, Laura L. Stafman, Evan F. Garner, Smitha Mruthyunjayappa, Jerry E. Stewart, Gregory K. Friedman, Jennifer M. Coleman, James M. Markert, G. Yancey Gillespie, Elizabeth A. Beierle
Опубликовано в: Translational Oncology (2016-10-01)